# DUSP19

## Overview
DUSP19, or dual specificity phosphatase 19, is a gene that encodes a protein of the same name, which functions as a dual-specificity phosphatase. This protein is involved in the regulation of key cellular signaling pathways by dephosphorylating both tyrosine and serine/threonine residues. As a member of the mitogen-activated protein kinase (MAPK) phosphatase family, DUSP19 plays a critical role in modulating pathways that govern cellular processes such as proliferation, differentiation, and stress responses (Wang2016DUSP19). The protein is active in both the cytoplasm and nucleus, where it influences the MAPK pathways, including the p38 and JNK pathways, and interacts with other signaling pathways such as NF-κB. DUSP19's regulatory functions have implications in various physiological and pathological contexts, including cardiac hypertrophy, osteoarthritis, spinal cord injury, and cancer, highlighting its potential as a therapeutic target (Xie2019DUSP19; Li2022Dualspecificity).

## Function
DUSP19 (dual specificity phosphatase 19) is a protein that plays a crucial role in regulating cellular signaling pathways by dephosphorylating both tyrosine and serine/threonine residues. It is involved in modulating the mitogen-activated protein kinase (MAPK) pathways, which are essential for various cellular processes such as proliferation, differentiation, and stress responses (Wang2016DUSP19). DUSP19 is active in both the cytoplasm and nucleus, where it influences these pathways.

In healthy human cells, DUSP19 functions as a MAPK phosphatase, specifically targeting and dephosphorylating apoptosis signal-regulating kinase 1 (ASK1), thereby inhibiting its phosphorylation. This action helps regulate the downstream pathways of p38 and JNK, which are key mediators in cellular stress responses and apoptosis (Li2022Dualspecificity). By modulating these pathways, DUSP19 plays a protective role in various tissues, including the heart, where it alleviates cardiac hypertrophy, and in chondrocytes, where it inhibits apoptosis during osteoarthritis pathogenesis (Wang2016DUSP19; Li2022Dualspecificity).

DUSP19 also interacts with the NF-κB signaling pathway, reducing inflammation and apoptosis in conditions such as spinal cord injury, highlighting its role in maintaining cellular homeostasis and protecting against inflammatory damage (Xie2019DUSP19).

## Clinical Significance
DUSP19 has been implicated in various diseases due to its role in modulating cellular signaling pathways. In spinal cord injury (SCI), DUSP19 expression is reduced, which correlates with increased levels of inflammatory cytokines IL-6 and IL-8, suggesting that DUSP19 may help mitigate inflammation and apoptosis in this context. Overexpression of DUSP19 in mouse models of traumatic spinal cord injury (TSCI) has been shown to inhibit the expression of phosphorylated NF-κBp65 and cleaved caspase-3, indicating its potential as a therapeutic target for reducing secondary injury in SCI (Xie2019DUSP19).

In pancreatic neuroendocrine tumors (pNETs), DUSP19 is involved in regulating tumor invasiveness through its interaction with VEGFR3. PTEN, a tumor suppressor, upregulates DUSP19, which in turn dephosphorylates VEGFR3, reducing its activity. Loss of PTEN leads to increased VEGFR3 phosphorylation and enhanced tumor invasiveness, highlighting the significance of DUSP19 in cancer progression. Alterations in DUSP19 expression or its interaction with VEGFR3 could impact the invasiveness and metastasis of pNETs, suggesting its potential clinical significance in cancer treatment (Chang2022PTEN).

## Interactions
DUSP19, a dual-specificity phosphatase, participates in several protein interactions that influence various signaling pathways. It directly interacts with VEGFR3, a receptor tyrosine kinase, in pancreatic neuroendocrine tumors (pNETs). This interaction facilitates the dephosphorylation of VEGFR3, which is crucial for regulating tumor invasiveness. The interaction was confirmed through immunoprecipitation and immunofluorescence staining, showing colocalization of DUSP19 and VEGFR3 on the cell membrane (Chang2022PTEN).

DUSP19 also interacts with components of the JNK signaling pathway. It has been shown to dephosphorylate JNK, although JNK does not directly bind to DUSP19. Instead, DUSP19 interacts with upstream MAPK kinases, particularly MKK7, which facilitates the dephosphorylation of JNK. DUSP19 may act as a scaffold protein within the JNK signaling cascade, enhancing the interaction between ASK1 and MKK7, which are upstream kinases in this pathway (Patterson2009Dualspecificity).

In the context of spinal cord injury, DUSP19 interacts with the NF-κB signaling pathway. Overexpression of DUSP19 inhibits the phosphorylation of NF-κB p65 and reduces the production of inflammatory cytokines, suggesting a protective role against inflammation and apoptosis (Xie2019DUSP19).


## References


[1. (Patterson2009Dualspecificity) Kate I. Patterson, Tilman Brummer, Philippa M. O’brien, and Roger J. Daly. Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochemical Journal, 418(3):475–489, February 2009. URL: http://dx.doi.org/10.1042/bj20082234, doi:10.1042/bj20082234. This article has 576 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20082234)

[2. (Wang2016DUSP19) Yang Wang, Zhengli Xu, Jialin Wang, and Shuogui Xu. Dusp19, a downstream effector of leptin, inhibits chondrocyte apoptosis via dephosphorylating jnk during osteoarthritis pathogenesis. Molecular BioSystems, 12(3):721–728, 2016. URL: http://dx.doi.org/10.1039/c5mb00776c, doi:10.1039/c5mb00776c. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1039/c5mb00776c)

[3. (Chang2022PTEN) Tsung-Ming Chang, Pei-Yi Chu, Hui-You Lin, Kuo-Wei Huang, Wen-Chun Hung, Yan-Shen Shan, Li-Tzong Chen, and Hui-Jen Tsai. Pten regulates invasiveness in pancreatic neuroendocrine tumors through dusp19-mediated vegfr3 dephosphorylation. Journal of Biomedical Science, November 2022. URL: http://dx.doi.org/10.1186/s12929-022-00875-2, doi:10.1186/s12929-022-00875-2. This article has 7 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/s12929-022-00875-2)

[4. (Xie2019DUSP19) Xian-Kuan Xie, Zheng-Kuan Xu, Kan Xu, and Yu-Xiang Xiao. Dusp19 mediates spinal cord injury-induced apoptosis and inflammation in mouse primary microglia cells via the nf-kb signaling pathway. Neurological Research, 42(1):31–38, December 2019. URL: http://dx.doi.org/10.1080/01616412.2019.1685068, doi:10.1080/01616412.2019.1685068. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/01616412.2019.1685068)

5. (Li2022Dualspecificity) Dual-specificity phosphatase 19 alleviates cardiac hypertrophy via inhibiting ASK1 phosphorylation. This article has 0 citations.